Authors: M. Šídová; P. Niederle Authors‘ workplace: Přednosta: prof. MUDr. Petr Niederle, DrSc. ; Kardiologické oddělení, Nemocnice Na Homolce Published in: Prakt. Lék. 2006; 86(9): 526-530 Category: Therapy
Non-steroidal anti-inflammatory drugs are the most used drugs in treatment of rheumatic diseases and pain. In the treatment of cardiovascular diseases aspirin is the widest used drug for its antiplatelet effect and plays the main role in secondary and primary prevention of ischemic events. Selective cyclooxygenase-2 inhibitors - coxibs are associated with increased risk of cardiovascular disease, tromboembolic events, and new onset of hypertension, congestive heart failure and worsening of pre-existing heart failure. As published studies show increased cardiovascular risk of coxibs, some of them were withdrawn from the global market. Cardiovascular risk of nonselective non-steroidal anti-inflammatory drugs is not yet clarified.
Key words: non-steroidal anti-inflammatory drugs, cyclooxygenase, prostaglandins, thromboxan, prostacyclin, coxibs
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
